Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Vikas Panibatla"'
Autor:
Karikalan Nagarajan, Karthikeyan Kumarswamy, Rehana Begum, Vikas Panibatla, Anil Singarajipura, Rajesham Adepu, Joseph Francis Munjattu, Senthil Sellapan, Stephen Arangba, Amrita Goswami, Reuben Swamickan, Javeed Basha, Pearl Maria Dsouza, Malaisamy Muniyandi
Publikováno v:
The Lancet Regional Health - Southeast Asia, Vol 22, Iss , Pp 100372- (2024)
Summary: Background: One-fifth of people with drug-resistance tuberculosis (DR-TB) who were initiated on newer shorter treatment regimen (with injection) had unfavourable treatment outcomes in India as on 2020. Evidence on self-driven solutions and r
Externí odkaz:
https://doaj.org/article/1d63eb20d79b4d5e90bb48b566fa2a67
Autor:
Vindhya Vatsyayan, Theresa Pattery, Khasim Sayyad, Jason Williams, Arnab Pal, Vikas Panibatla, Ashwani Khanna
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundThe National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all
Externí odkaz:
https://doaj.org/article/96f9e39d566c4f848bea313d8a669570
Autor:
Reynold Washington, Rajaram Subramanian Potty, A. Rajesham, T. Seenappa, Anil Singarajipura, Reuben Swamickan, Amar Shah, K. H. Prakash, Arin Kar, Karthikeyan Kumaraswamy, B. S. Prarthana, Bala Krishna Maryala, J. Sushma, Ramesh Dasari, Bharath Shetty, Vikas Panibatla, H. L. Mohan, Marissa Becker
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background TB is a preventable and treatable disease. Yet, successful treatment outcomes at desired levels are elusive in many national TB programs, including India. We aim to identify risk factors for unfavourable outcomes to TB treatment,
Externí odkaz:
https://doaj.org/article/a11cac5b6d4d4f19886a4e936c601729
Autor:
Karikalan Nagarajan, Karthikeyan Kumarsamy, Rehana Begum, Vikas Panibatla, Rameshchandra Reddy, Rajesham Adepu, Joseph Francis Munjattu, Senthil Sellapan, Stephen Arangba, Amrita Goswami, Reuben Swamickan, Malaisamy Muniyandi
Publikováno v:
Antibiotics, Vol 11, Iss 11, p 1586 (2022)
Qualitative insights regarding psycho-social barriers and challenges experienced by drug-resistant tuberculosis (DR-TB) patients and their caregivers are understudied in India. We conducted a qualitative study using semi-structured qualitative interv
Externí odkaz:
https://doaj.org/article/4f6387782eff412a8e46e24f013fa934
Autor:
Santosha Kelamane, Srinath Satyanarayana, Sharath Burugina Nagaraja, Vikas Panibatla, Ramesh Dasari, Rajeesham, Amera Khan, Vishnuvardhan Kamineni
Publikováno v:
Tuberculosis Research and Treatment, Vol 2021 (2021)
Background. Informal (unqualified) health care providers are an important source of medical care for persons with presumptive TB (PPTB) in India. A project (titled RIPEND) was implemented to engage informal providers for the identification of PPTBs a
Externí odkaz:
https://doaj.org/article/2279a34bad444994a16ab4f77941cab6
Autor:
Tushar Garg, Vikas Panibatla, Joseph P. Carel, Achanta Shanta, Manish Bhardwaj, Miranda Brouwer
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 6, Iss 4, p 200 (2021)
Navigating the Indian health system is a challenge for people with tuberculosis (TB) symptoms. The onus of organizing care is on the patient and their families alone. Factors like gender discrimination and opportunity costs further aggravate this. As
Externí odkaz:
https://doaj.org/article/4917fb3317e9401882e27128e955967a
Autor:
Vindhya Vatsyayan, Theresa Pattery, Khasim Sayyad, Jason Williams, Arnab Pal, Vikas Panibatla, Ashwani Khanna
Publikováno v:
Journal of Tuberculosis Research. 10:187-198
Autor:
Rajaram Subramanian, Potty, Karthikeyan, Kumarasamy, Joseph F, Munjattu, Ramesh C, Reddy, Rajesham, Adepu, Anil, Singarajipura, Mohan H, Lakkappa, Reuben, Swamickan, Amar, Shah, Vikas, Panibatla, Reynold, Washington
Publikováno v:
Bulletin of the World Health Organization. 101(1)
To assess treatment outcomes in tuberculosis patients participating in support group meetings in five districts of Karnataka and Telangana states in southern India.Tuberculosis patients from five selected districts who began treatment in 2019 were of
Autor:
Arin Kar, J. Sushma, Reynold Washington, T. Seenappa, Reuben Swamickan, Marissa Becker, Rajaram Subramanian Potty, K. H. Prakash, Ramesh Dasari, Vikas Panibatla, Anil Singarajipura, B. S. Prarthana, Bala Krishna Maryala, H L Mohan, Karthikeyan Kumaraswamy, Amar Shah, Bharath Shetty, A. Rajesham
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-12 (2020)
BMC Public Health
BMC Public Health
Background TB is a preventable and treatable disease. Yet, successful treatment outcomes at desired levels are elusive in many national TB programs, including India. We aim to identify risk factors for unfavourable outcomes to TB treatment, in order
Autor:
Achanta Shanta, Joseph P. Carel, Tushar Garg, Manish Bhardwaj, Vikas Panibatla, Miranda Brouwer
Publikováno v:
Tropical Medicine and Infectious Disease
Tropical Medicine and Infectious Disease, Vol 6, Iss 200, p 200 (2021)
Tropical Medicine and Infectious Disease; Volume 6; Issue 4; Pages: 200
Tropical Medicine and Infectious Disease, Vol 6, Iss 200, p 200 (2021)
Tropical Medicine and Infectious Disease; Volume 6; Issue 4; Pages: 200
Navigating the Indian health system is a challenge for people with tuberculosis (TB) symptoms. The onus of organizing care is on the patient and their families alone. Factors like gender discrimination and opportunity costs further aggravate this. As